MacroGenics
MGNX
#9332
Rank
โ‚น14.51 B
Marketcap
โ‚น227.88
Share price
0.84%
Change (1 day)
60.69%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): -โ‚น49.67

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น54.12. In 2025 the company made an earnings per share (EPS) of -โ‚น112.04 a decrease over its 2024 EPS that were of -โ‚น101.60.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น49.67-55.67%
2025-โ‚น112.0410.28%
2024-โ‚น101.60613.33%
2023-โ‚น14.24-92.31%
2022-โ‚น185.15-42.14%
2021-โ‚น319.9836.44%
2020-โ‚น234.53-21.84%
2019-โ‚น300.04-24.58%
2018-โ‚น397.84675.93%
2017-โ‚น51.27-68.05%
2016-โ‚น160.47168.25%
2015-โ‚น59.82-55%
2014-โ‚น132.933400%
2013-โ‚น3.80-108.68%
2012โ‚น43.7724.49%
2011โ‚น35.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น72.16-233.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,837-5,342.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,540-2,945.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น246.87 356.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น120.16-322.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น431.07-896.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น206.04 280.70%๐Ÿ‡บ๐Ÿ‡ธ USA